Nanobiotix

YTD

ALL

Why Robinhood?

You can watch Nanobiotix and buy or sell other stocks, options, and ETFs commission-free!

About NBTX

Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells.

CEO

Laurent Lévy

CEOLaurent Lévy

Employees

102

Employees102

Headquarters

Paris, Ile-de-France

HeadquartersParis, Ile-de-France

Founded

2003

Founded2003

Employees

102

Employees102

NBTX Key Statistics

Market cap

347.88M

Market cap347.88M

Price-Earnings ratio

-6.25

Price-Earnings ratio-6.25

Dividend yield

—

Dividend yield—

Average volume

6.19K

Average volume6.19K

High today

—

High today—

Low today

—

Low today—

Open price

$7.49

Open price$7.49

Volume

0.00

Volume0.00

52 Week high

$11.00

52 Week high$11.00

52 Week low

$4.55

52 Week low$4.55

NBTX News

TipRanks 16h

Nanobiotix Announces Latest Share and Voting Rights Update - TipRanks.com - TipRanks

Nanobiotix Sa ADR (NBTX) has released an update. Nanobiotix, a pioneering biotechnology company, has updated its total number of shares and voting rights, in c...

TipRanks 2d

Nanobiotix Prepares to Unveil Q1 2024 Results - TipRanks.com - TipRanks

Nanobiotix Sa ADR (NBTX) has released an update. Nanobiotix, a company at the forefront of developing physics-based cancer treatments, is slated to reveal its...

TipRanks 3d

Nanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study

Nanobiotix (NBTX) announced that the FDA issued a Study May Proceed Letter for a randomized Phase 2 study evaluating NBTXR3 for the treatment of patients with s...

More NBTX News

Simply Wall St 3d

Subdued Growth No Barrier To Nanobiotix S.A. With Shares Advancing 26% - Simply Wall St

Nanobiotix S.A. ( ) shareholders are no doubt pleased to see that the share price has bounced 26% in the last month, although it is still struggling to make up...